1-4 of 4
Laura Michaelis, MD
Close
Sort by
Journal Articles

Title: Promoter Methylation of Selected Genes and Response to Azacitidine (AZ) Therapy in Patients with Non-BCR-ABL Myeloproliferative Disorders (MPDs)

Nicholas Achille, BS, Laura Michaelis, MD, Scott E. Smith, MD, PhD, FACP, Eliza Germano, Nancy J. Zeleznik-Le, PhD, Sucha Nand, MD
Journal: Blood
Blood (2011) 118 (21): 4625.
https://doi.org/10.1182/blood.V118.21.4625.4625
Published: 2011
Journal Articles

Rearrangements of the MLL Gene Are Influenced by DNA Secondary Structure, Potentially Mediated by Topoisomerase II Binding

Hongan Le, Sabine Schnyder, MD, Nga Du, Grace Loredo, Ph.D, Sheetal Singh, Ph.D, Shyh-Jen Shih, Ph.D, Laura Michaelis, MD, Christine Bien, Manuel Diaz, MD, Andrew T.M. Vaughan, PhD
Journal: Blood
Blood (2008) 112 (11): 3105.
https://doi.org/10.1182/blood.V112.11.3105.3105
Published: 2008
Journal Articles

A Randomized Phase IIa Study of Vorinostat in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes: Preliminary Results

Guillermo Garcia-Manero, MD, Lewis B. Silverman, MD, Ivana Gojo, MD, Laura Michaelis, MD, Simrit Parmar, Stuart L Goldberg, Hagop M. Kantarjian, Jose Garcia-Vargas, Syed Rizvi, Karl Heath, Azra Raza
Journal: Blood
Blood (2008) 112 (11): 5084.
https://doi.org/10.1182/blood.V112.11.5084.5084
Published: 2008
Journal Articles

Alemtuzumab (Campath 1-H) Exposure Correlates with Risk of Chronic Graft vs Host Disease and CMV Viremia after Allogeneic Transplantation.

Justin P. Kline, MD, Rajiv Swamy, MD, Dezheng Huo, Laura Michaelis, MD, Richard A. Larson, MD, Elizabeth Rich, MD, PhD, Wendy Stock, MD, Jody Ulaszek, MS, Amittha Wickrema, PhD, Andrew Artz, MD, Maher Albitar, MD, Koen van Besien, MD
Journal: Blood
Blood (2005) 106 (11): 1818.
https://doi.org/10.1182/blood.V106.11.1818.1818
Published: 2005